Statistics
Total Visits
| Views | |
|---|---|
| Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: Pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials | 192 |
Total Visits Per Month
| March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | |
|---|---|---|---|---|---|---|---|
| Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: Pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials | 1 | 2 | 3 | 5 | 2 | 8 | 0 |
Top country views
| Views | |
|---|---|
| United States | 92 |
| Poland | 52 |
| Ireland | 16 |
| China | 13 |
| Sweden | 8 |
| Canada | 2 |
| France | 2 |
| Iran | 2 |
| Mongolia | 2 |
| Australia | 1 |
Top cities views
| Views | |
|---|---|
| Warsaw | 52 |
| Louisville | 19 |
| Dublin | 16 |
| Fairfield | 11 |
| Des Moines | 10 |
| San Ramon | 7 |
| Boardman | 6 |
| San Mateo | 5 |
| Ann Arbor | 4 |
| Beijing | 4 |